YUMANITY THERAPEUTICS INC (YMTX) Stock Analyst Earnings Estimates
NASDAQ:YMTX - Nasdaq - US98872L1026 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5M 76.06% | 6.9M 38.00% | 8.044M 16.58% | 10.2M 26.80% | 12.24M 20.00% | -100.00% | |||
| EBITDA YoY % growth | -59.74M 2.70% | -54.86M 8.17% | -38.114M 30.52% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -61.15M 3.21% | -55.63M 9.03% | -38.745M 30.35% | -43.35M -11.89% | -54.06M -24.71% | -86.459M -59.93% | -48.893M 43.45% | -28.202M 42.32% | |
| Operating Margin | -1,223.00% | -806.23% | -481.66% | -425.00% | -441.67% | N/A | N/A | N/A | |
| EPS YoY % growth | -23.00 28.57% | -5.44 76.35% | -3.85 29.23% | -6.18 -60.56% | -9.80 -58.50% | -8.00 18.38% | -4.82 39.67% | -2.97 38.47% |
All data in USD
| Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.17 -17.30% | -1.25 -42.57% | -1.28 -183.33% | -1.26 -308.00% | -1.26 -7.83% |
| Revenue Q2Q % growth | 3.06M 301.57% | 2.55M 149.27% | 3.06M 84.67% | 3.06M 118.26% | 3.57M 16.67% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -12.24M -22.14% | -13.26M -52.45% | -13.515M -168.10% | -13.515M -285.70% | -13.77M -12.50% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.31 68.04% | -1.10 | 0.79 | 71.86% |
| Q2 2022 Q2Q % growth | -0.45 56.31% | -1.01 | 0.56 | 55.44% |
| Q1 2022 Q2Q % growth | -0.88 -3.53% | -0.97 | 0.09 | 9.18% |
| Q4 2021 Q2Q % growth | -1.00 -125.25% | -1.07 | 0.07 | 6.92% |
| Q3 2021 Q2Q % growth | -0.97 55.91% | -1.15 | 0.18 | 15.84% |
| Q2 2021 Q2Q % growth | -1.03 69.71% | -0.86 | -0.17 | -20.21% |
| Q1 2021 Q2Q % growth | -0.85 77.63% | -0.85 | 0.00 | -0.40% |
| Q4 2020 Q2Q % growth | 3.96 186.09% | -2.86 | 6.82 | 238.66% |
| Q3 2020 Q2Q % growth | -2.20 56.00% | -3.67 | 1.47 | 40.09% |
| Q2 2020 Q2Q % growth | -3.40 56.41% | -4.34 | 0.94 | 21.57% |
| Q1 2020 Q2Q % growth | -3.80 32.14% | -5.20 | 1.40 | 26.95% |
| Q4 2019 Q2Q % growth | -4.60 | -5.87 | 1.27 | 21.57% |
| Q3 2019 Q2Q % growth | -5.00 | -8.26 | 3.26 | 39.48% |
| Q2 2019 Q2Q % growth | -7.80 | -7.68 | -0.12 | -1.51% |
| Q1 2019 Q2Q % growth | -5.60 | -8.01 | 2.41 | 30.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 1.402M -14.25% | 2.55M | -1.148M | -45.02% |
| Q2 2022 Q2Q % growth | 1.657M -21.62% | 2.55M | -893K | -35.02% |
| Q1 2022 Q2Q % growth | 1.023M -71.02% | 2.04M | -1.017M | -49.85% |
| Q4 2021 Q2Q % growth | 762K -88.96% | 1.842M | -1.08M | -58.63% |
| Q3 2021 Q2Q % growth | 1.635M | 1.972M | -337K | -17.09% |
| Q2 2021 Q2Q % growth | 2.114M | 2.312M | -198K | -8.56% |
| Q1 2021 Q2Q % growth | 3.53M | 2.311M | 1.219M | 52.75% |
| Q2 2020 Q2Q % growth | 127.5K | -127.5K | -100.00% | |
| Q1 2020 Q2Q % growth | -100.00% | 306K | -306K | -100.00% |
| Q4 2019 Q2Q % growth | 191.25K | -191.25K | -100.00% | |
| Q3 2019 Q2Q % growth | 510K | -510K | -100.00% | |
| Q2 2019 Q2Q % growth | 816K | -816K | -100.00% | |
| Q1 2019 Q2Q % growth | 5M | 527.003K | 4.473M | 848.76% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | -45.33% | N/A |
| Revenue | 0% | N/A | 0% | N/A |